The non-steady state metabolism of inhalation anaesthetics during anaesthesia and recovery was simulated with a linear and non-linear whole body compartmental model. These two models were studied for nine anaesthetics during 1-MAC anaesthesias lasting 1, 4 and 8 h and recovery from 5 to 10 days. Both models demonstrated significant metabolism for several days following anaesthesia. For the linear model, both the percentage and the molar quantity of anaesthetic metabolized increased with increased duration of anaesthesia, increased anaesthetic fat solubility and increased assumed rate of hepatic metabolism. For the non-linear model, the duration of anaesthesia had little effect on the percentage metabolized but demonstrated increased molar quantities of anaesthetic metabolized with increased duration of anaesthesia and increased fat solubility. The agreement between the results obtained from the non-linear model and experimental data in the literature suggests that many inhalation anaesthetics belong to a class of xenobiotics whose biotransformation is limited by the same or similar non-linear rate-limiting step(s). A difference in the quantities of anaesthetic metabolized would be a direct consequence of the tissue solubilities of the anaesthetic.
At time zero, the arterial concentration was increased to a clinical concentration equivalent to the minimum alveolar concentration (MAC) (Eger, Saidman and Brandstater, 1965) . This arterial concentration was maintained for the duration of anaesthesia. During recovery the arterial concentration was calculated from the venous concentration and the pulmonary clearance of anaesthetic determined by the alveolar ventilation (4.8 litre/min), cardiac output (6 litre/min) and the appropriate blood/gas partition coefficient (Stewart et al., 1973 ). The recovery was followed for 5-10 days. The simulation parameters are in table I.
Uptake during anaesthesia was calculated by subtracting the venous from the arterial concentration and multiplying the difference by the cardiac output. The program printed the instantaneous and cumulative molar anaesthetic uptake and the instantaneous and cumulative molar amounts metabolized.
The MIMIC program automatically reduces the integrating interval to obtain a local relative error less than 5 x 10~6. The effect of this automatic feature on the simulations was confirmed by reducing the integrating interval manually and noting no change in results.
Two models for the metabolism of an inhalation anaesthetic were studied. The linear model assumes first-order kinetics causing a constant fraction (HF) (Appendix A) of the anaesthetic delivered to the liver to be metabolized. The HF values studied were 0.02, 0.06 and 0.18. The non-linear model (NL) uses an approximation of a published , in vivo nonlinear relationship between the hepatic arterial concentration and HF (Appendix B). NL assumes that at the same molar arterial concentration each anaesthetic is biotransformed to the same extent as halothane. The position of the molar arterial concentrations at MAC on a portion of the hepatic metabolism function used for NL is shown in figure 1 . As a result of this assumption, anaesthetics with greater molar arterial concentrations at MAC, such as diethyl ether (0.84 mmol/100 ml), have a lower fraction metabolized during anaesthesia than agents with lower molar arterial concentration at MAC, such as methoxyflurane (0.06 mmol/100 ml). The description of the quantities of anaesthetic metabolized by these two models during and following anaesthesia were expressed in the relative (PM) and absolute (MM) units. PM is convenient for comparing the susceptibility of anaesthetics to biotransformation. MM is useful for studying the toxicology of an anaesthetic.
RESULTS

Amounts of anaesthetic metabolized
The simulated relative (PM) and absolute (MM) amounts of anaesthetic metabolized during anaesthesia and recovery with the linear and non-linear models are displayed in order of the fat/gas partition coefficient in tables II and III. With both models diethyl ether and chloroform produce the greatest MM. However, the relative order of anaesthetics by PM is different in the two models. In NL, methoxyflurane produces the largest PM and diethyl ether one of the lowest. In the linear model methoxyflurane and diethyl ether share the position of greatest PM.
Instantaneous and cumulative percentage metabolized during anaesthesia
During anaesthesia, tissue uptake decreases as tissue anaesthetic tensions equilibrate with the arterial anaesthetic tension. For both models a constant arterial concentration causes a constant rate of anaesthetic metabolism in the liver. However, the instantaneous rate of metabolism expressed as the proportion of uptake (IPU) increases with increasing time. For an infinitely long anaesthetic, assuming negligible losses from urine and exposed body surfaces (Stoelting and Eger, 1969) , IPU approaches 100%. Even small HF values account for significant IPU values after saturation of the well-perfused tissues during the first hours of anaesthesia. When the percentage of uptake metabolized during anaesthesia is described cumulatively (CPU), the numerical value is less. Whereas IPU becomes meaningless during recovery, CPU remains meaningful as it increases towards PM. These points are illustrated for methoxyflurane using the linear model ( fig. 2 ). For HF = 0.02, at 2 h IPU was 4.7%; at 4 h IPU was 7.2%. CPU for these same times were 2.2% and 3.9%. IPU and CPU increased as HF increased for the 0.06 and 0.18 HF.
PM is of little help in estimating IPU. The metabolism of fluroxene and of methoxyflurane was simulated with the linear model assuming 0.06 HF, 4 h of anaesthesia, and 10 days recovery. At the end of anaesthesia IPU was 19% for methoxyflurane and 26% for fluroxene. During recovery, fluroxene was eliminated rapidly producing PM of 15%. Methoxyflurane, however, was eliminated slowly. CPU at 1 day was 17%; 5 days, 21%; and PM at 10 days 23%. For methoxyflurane PM overestimates (23%) the 4-h IPU; for fluroxene PM underestimates (-7*3%) the 4-h IPU.
Duration of anaesthesia and recovery
Studies with methoxyflurane suggest that longer anaesthetic exposures result in greater amounts metabolized (Mazze, Cousins and Kosek, 1972; Cousins and Mazze, 1973) . The percentage increase, however, depends on whether metabolism is expressed as PM or MM. I2E0 Referring to the 0.06 HF columns of table II, it can be seen that as the duration of anaesthesia doubled from 4 to 8 h, PM for fluroxene increased from 15% to 19% (27% increase). PM for methoxyflurane increased less, from 23% to 26% (13% increase). This relatively small increase in PM for both fluroxene and methoxyflurane was associated with a large increase in MM. For fluroxene MM increased from 43 to 82 mmol (91% increase) and for methoxyflurane from 28 to 47 mmol (68% increase).
As the duration of anaesthesia increased from 1 to 4 to 8 h the increases in MM and PM were greater for the linear model. In NL (table III) MM increased also with increased duration of anaesthesia. However, PM changed little and decreased for chloroform and diethyl ether.
With both models, significant anaesthetic metabolism continued for several days following anaesthesia. This is illustrated by showing the percentage of PM occurring at several intervals following a 1-h anaesthetic (table IV) . Metabolism was virtually complete in 2 days for diethyl ether and fluroxene. For methoxyflurane and trichloroethylene, significant metabolism continued for 5 days following anaesthesia. For all anaesthetics the time, following anaesthesia, during which metabolism occurred increases in NL. The greatest difference occurs with fluroxene ( fig. 3) .
Anaesthetics with greater solubility in lipid or blood were retained in the body longer resulting in greater cumulative exposure. In NL, PM correlated with the fat solubility of the anaesthetic (fig. 4) linear model PM correlated better with the blood/gas partition coefficient.
DISCUSSION
The rate at which the liver metabolizes anaesthetics is a function of both the quantity delivered to the hepatic enzymes and the susceptibility of the anaesthetic to biotransformation.
The amount of anaesthetic metabolized should be dependent on concentration and should follow Michaelis-Menten enzyme kinetics (Michaelis and Menten, 1913; Gibaldi, 1971; Wagner, 1973) . The amount of anaesthetic metabolized may be a constant fraction of the arterial concentration (first-order kinetics), may be inversely related to arterial concentration, or may be a constant independent of arterial concentration (zero-order kinetics). The linear model assumes first-order kinetics while NL assumes that the enzymes become saturated, approaching zeroorder kinetics during anaesthesia.
Several determinants of anaesthetic biotransformation were not included in this simulation study. The metabolites are generally less lipophilic and more water soluble than the parent compound and therefore achieve tissue saturation more rapidly than the parent compounds. The effect of these metabolites on biotransformation was not considered. The kidney and, perhaps, the lung metabolize small amounts of anaesthetics (Paul and Rubinstein, 1963) ; nevertheless, extrahepatic sites of metabolism were ignored.
The simulations do not account for drug interactions. Microsomal induction occurs with inhalation anaesthetics (Linde and Berman, 1971) and drugs administered in the operative period (Berman et al., 1973; Brown, 1973) . Changes in cardiac output, alveolar ventilation, body temperature, hepatic blood flow during anaesthesia and recovery would also alter the simulated quantities of anaesthetic biotransformed.
In spite of known species variations in biotransformation and problems of scaling a model (Dedrick, 1974) from the pig to man, the results from NL were remarkably consistent with the sparse human data. Halothane metabolism with NL for 1 h of anaesthesia predicts 24% PM. This is in reasonable agreement with the 18% reported by Rehder and others (1967) and the 10-23% reported by Cascorbi, Blake and Helrich (1970) . NL predicts 12% PM for fluroxene after 1 h of anaesthesia. This is consistent with the finding of 12-15% biotransformation by Blake and Cascorbi (1970) . NL predicts 51-54% PM for methoxyflurane, which compares favourably with the 47% reported by Holaday, Rudofsky and Truhaft (1970) . The order of decreasing PM, methoxyflurane, halothane, fluroxene, cyclopropane is consistent with a variety of experimental results.
A notable exception to the success of NL is the simulation of enflurane and isoflurane biotransformation. Published data (Chase et al., 1971; Halsey et al., 1971; Holaday et al., 1975) suggest that isoflurane is metabolized much less than enflurane, and that both are metabolized less than fluroxene (Gion et al., 1974) . However, NL predicts similar quantities metabolized for enflurane and isoflurane, both greater than fluroxene. This discrepancy suggests that enflurane and isoflurane are either biotransformed by a different metabolic pathway or have significantly different susceptibilities to biotransformation.
The relationship between the molar amount of an anaesthetic metabolized (MM) and organ toxicity depends on the toxicologic properties of the biotransformed anaesthetic. Both models suggest that diethyl ether undergoes significant biotransformation. However, clinical experience suggests that the biotransformed diethyl ether has negligible lasting toxicity. Methoxyflurane metabolism may result in fewer millimoles metabolized than does diethyl ether metabolism, yet these products have established dose-related organ toxicity.
Two assumptions of NL remain controversial: (1) Is the molar rate of hepatic biotransformation similar for most anaesthetics ? (2) Is the rate of biotransformation inversely proportional to the arterial concentration ? The success of NL for predicting PM values consistent with in vivo studies suggests that pharmacokinetic considerations of metabolism are as important as the biochemical determinants of anaesthetic metabolism during the non-steady state of clinical anaesthesia. 
PHARMACOCINETIQUE DU METABOLISME DES ANESTHESIANTS PAR INHALATION
Etude d'une simulation RESUME On a simule a l'aide d'un modele compartimente de corps entier, line'aire et non line'aire, le metabolisme a l'etat non soutenu des anesthesiants par inhalation pendant l'anesth£sie et le reveil. Ces deux modeles ont 6te Studies sur neuf anesth£siants au cours d'anesthe'sies utilisant une concentration alveolaire minimale durant 1, 4 et 8 h, le reveil demandant de 5 a 10 jours. Les deux modeles ont accuse un mStabolisme significatif pendant plusieurs jours apres l'anesthesie. En ce qui concerne le modele lin£aire, le pourcentage tout comme la quantity molaire de l'anesthesiant metabolise ont augmente en fonction de raugmentation de la dur6e de l'anesthesie, de l'augmentation de la solubilite des matieres grasses de l'anesthe'siant et de l'-augmentation du taux presume du mitabolisme h£patique. En ce qui concerne le modele non lin£aire, la dur6e de I'anesth6sie n'a eu que peu d'effet sur le pourcentage metabolise, mais il a accuse une augmentation des quantites molaires de PanesthSsiant metabolise 1 avec raugmentation de la dur£e le l'anesthSsie et de la solubilite des matieres grasses. L'accord entre les r£sultats que l'on a obtenus du modele non lineaire et les donnees exp^rimentales figurant dans la documentation laissent penser que de nombreux anesthesiants par inhalation appartiennent a une cat£gorie de x6nobiotiques dont la biotransformation est limitee par la ou les memes mesures ou par des mesures similaires non lineaires limitatrices du taux. Une difference dans les quantites de l'anesth&iant metabolism serait une consequence directe de la solubility des tissus par I'anesth6siant. 
PHARMAKOKINETIK DES STOFFWECHSELS DER INHALATIONSANASTHESIE
SUMARIO
El metabolismo de regimen inestable de los aneste'sicos de inhalacion durante la anestesia y recuperacion fue simulado con un modelo compartamental lineal y no lineal de cuerpo entero. Estos dos modelos fueron estudiados con nueve anest£sicos durante anestesia de 1 concentracion alveolar minima (CAM) que dur6, respectivamente, 1, 4 y 8 h y recuperacion de 5 a 10 dias. Ambos modelos demostraron un significante metabolismo durante varios dias consecutivo a la anestesia. En el modelo lineal, el porcentaje y la cantidad molar de anestesico metabolizado aumento segiin aumentaba la duracion de la anestesia, aumento la solubilidad de grasa por el anest£sico, y aumento el indice asumido del metabolismo hepatico. En el modelo no lineal la duracion de la anestesia ejercio poco efecto en el pocentaje metabolizado pero mostro cantidades molares aumentadas de anestesico metabolizado con duracidn aumentada de la anestesia y aumento en la solubilidad de grasa. La concordancia entre los resultados obtenidos con el modelo no lineal y los datos experimentales en la literatura sugiere que muchos anestesicos de inhalaci6n pertenecen a una clase de xenobi6ticos cuya biotransformacion esta limitada por la(s) etapa(s) similar(es) o idintica(s) no lineal(es) limitadora(s) del indice. Una diferencia en las cantidades metabolizadas de anesresico seria consecuencia directa de las solubilidades histicas del anestesico.
